Emerson Electric Co (EMR) Receives Outperform Rating from Evercore

2 min readBy Investing Point Editorial Team

Evercore ISI Group has initiated coverage on Emerson Electric Co (EMR) with an Outperform rating, marking the firm's first assessment of the company's investment potential. This decision reflects a positive outlook on Emerson's business dynamics and growth prospects in the electrical equipment industry.

Headquartered in St. Louis, Missouri, Emerson Electric Co is a global technology and software company that provides a range of solutions across various sectors. The company operates through two main business groups: Intelligent Devices and Software and Control. The Intelligent Devices segment encompasses Final Control, Measurement & Analytical, Discrete Automation, and Safety & Productivity, while the Software and Control group includes Control Systems & Software, Test & Measurement, and AspenTech. Emerson's diverse offerings position it well within the market, catering to the needs of industrial manufacturers.

As of December 14, 2025, Emerson's stock is priced at $137.26. The company boasts a market capitalization of $77.9 billion, a P/E ratio of 33.97, and an impressive dividend yield of 162.0%. Upcoming earnings reports are scheduled, with estimates for August 4, 2026, projecting an EPS of $1.69 and revenue of $4.9 billion.

Analyst ratings, such as this one from Evercore, provide insights based on extensive research and financial modeling. While they can serve as valuable indicators, investors are advised to consider a range of factors, including company fundamentals and market trends, when making decisions. Analyst opinions can shift over time as new information becomes available, underscoring the importance of a comprehensive approach to investment strategies.

This brief was generated from structured financial data and reviewed by the Investing Point editorial team. It is for informational purposes only and does not constitute investment advice. Market data provided by Finnhub.

Related Stocks

More in this Category

Analyst Ratings

Explore more analyst ratings or view detailed analysis for EMR stock.